Innovating science and practice - Broadening the understanding of PCSK9i mAb
Online program on novel findings and outcomes from clinical research with PCSK9i mAb in 2022.
Episodes 1-3 of 3
- Innovating science and practice - Broadening the understanding of PCSK9i mAbInitiating PCSK9 mAb after ACS: When and how to start?
Prof. Wouter Jukema, MD, PhD
Prof. Pasquale Perrone-Filardi, MD, PhD
- Innovating science and practice - Broadening the understanding of PCSK9i mAbEffects of intensive lipid lowering on coronary plaque characteristics
Prof. Lorenz Räber, MD, PhD
Prof. Stephen Nicholls, MD
- Innovating science and practice - Broadening the understanding of PCSK9i mAbReal-world evidence with PCSK9i mAb; implications and lessons for current clinical use
Raul Santos, MD, PhD
Prof. Maciej Banach, MD, PhD
